News tagged with tumor response
Glitches in DNA repair genes predict prognosis in pancreatic cancer
Jan 14, 2009 |
5 / 5 (1) |
0
Variations in mismatch repair genes can help predict treatment response and prognosis in patients with pancreatic cancer, according to research from The University of Texas M. D. Anderson Cancer Center presented today in ...
Angiogenesis inhibitor improves brain tumor survival by reducing edema
Mar 30, 2009 |
not rated yet |
0
The beneficial effects of anti-angiogenesis drugs in the treatment of the deadly brain tumors called glioblastomas appear to result primarily from reduction of edema - the swelling of brain tissue - and not from any direct ...
CT imaging taken post avastin may predict survival in patients with metastatic colorectal cancer
Dec 01, 2009 |
not rated yet |
0
Using routine computed tomography (CT) imaging to analyze form and structural changes to colorectal liver metastasis after bevacizumab and chemotherapy may predict overall survival, according to research from The University ...
Search results for tumor response
Scientists discover genetic pattern that indicates early-stage lung cancer
Dec 01, 2009 |
4 / 5 (1) |
0
Wistar Institute researchers and collaborators from the University of Pennsylvania and New York University have identified immune system markers in the blood which indicate early-stage lung tumors in people at high risk for ...
Pancreatic tumors are marked for immunotherapy
Nov 30, 2009 |
not rated yet |
0
Pancreatic tumors can be identified by a readily detectable marker that shows promise as a basis for immune therapy against the disease, according to research at Washington University School of Medicine in St. Louis.
Clinical trials launched for treating most aggressive brain tumor with personalized cell vaccines
Nov 30, 2009 |
not rated yet |
0
The University of Navarra Hospital (Spain) has launched a series of clinical trials in order to assess the efficacy of an immunotherapy treatment. This approach involves the application of personalised vaccines —produced ...
Estrogen receptor-alpha, breast cancer patients and tamoxifen response
Nov 25, 2009 |
not rated yet |
0
Researchers have found evidence of a statistically significant survival benefit from adjuvant tamoxifen among patients whose estrogen receptor (ER)-positive tumors had high levels of phosphorylation of ER-alpha; at serine-118 ...
Implant-based cancer vaccine is first to eliminate tumors in mice
Nov 25, 2009 |
4.7 / 5 (31) |
7
(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...
Common pain relief medication may encourage cancer growth
Nov 18, 2009 |
5 / 5 (3) |
0
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of ...
Magnetic Nanotags Spot Cancer in Mice Earlier Than Current Methods
Nanotechnology / Bio & Medicine
Nov 17, 2009 |
3 / 5 (2) |
0
(PhysOrg.com) -- Searching for biomarkers that can warn of diseases such as cancer while they are still in their earliest stage is likely to become far easier thanks to an innovative biosensor chip developed by Stanford University ...
The indefinite self-renewal of specialized cells without the need for stem cell intermediates
Nov 16, 2009 |
3.7 / 5 (3) |
1
(PhysOrg.com) -- Is the indefinite expansion of adult cells possible without recourse to stem cell intermediates? The team led by Michael Sieweke at the Centre d'immunologie de Marseille Luminy, France has ...
Imaging techniques may help predict response to head and neck cancer treatment
Nov 16, 2009 |
not rated yet |
0
A combination of imaging tests conducted six to eight weeks after patients complete chemoradiotherapy for head and neck cancer may help identify patients who will respond to treatment and those who will require surgical follow-up, ...
How cells tolerate DNA damage -- start signal for cell survival program identified
Nov 16, 2009 |
not rated yet |
0
Cancer researchers of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch, Germany, have gained new insights into how cells react to DNA damage. Dr. Michael Stilmann, Dr. Michael Hinz and Professor Claus Scheidereit ...
List of search results for tumor response
